Michael G. Kauffman

2015

In 2015, Michael G. Kauffman earned a total compensation of $4.6M as Chief Executive Officer at Karyopharm Therapeutics, a 602% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$150,000
Option Awards$3,896,500
Salary$500,000
Other$10,980
Total$4,557,480

Kauffman received $3.9M in option awards, accounting for 85% of the total pay in 2015.

Kauffman also received $150K in non-equity incentive plan, $500K in salary and $11K in other compensation.

Rankings

In 2015, Michael G. Kauffman's compensation ranked 1,820th out of 13,638 executives tracked by ExecPay. In other words, Kauffman earned more than 86.7% of executives.

ClassificationRankingPercentile
All
1,820
out of 13,638
87th
Division
Manufacturing
655
out of 5,190
87th
Major group
Chemicals And Allied Products
241
out of 1,854
87th
Industry group
Drugs
187
out of 1,528
88th
Industry
Pharmaceutical Preparations
150
out of 1,182
87th
Source: SEC filing on April 28, 2017.

Kauffman's colleagues

We found three more compensation records of executives who worked with Michael G. Kauffman at Karyopharm Therapeutics in 2015.

2015

Sharon Shacham

Karyopharm Therapeutics

Chief Scientific Officer

2015

Christopher Primiano

Karyopharm Therapeutics

General Counsel

2015

Justin Renz

Karyopharm Therapeutics

Chief Financial Officer

News

In-depth

You may also like